The final bill was $63,976.35, charged by the hospital — which was not in-network with the insurance plan she got through her job — for the surgery and overnight stay.

As the consumer health company battles claims from the Trump administration that its painkiller Tylenol is linked to autism, Kenvue will bring on Halvorson as its next marketing chief.

Taking place March 31 in New York, the annual event will help marketers and healthcare agencies stay ahead of industry changes.

Email to staff says information including bank and payroll number, salary, National Insurance number, and personal contact details have been taken.

The Trump administration took another step Tuesday to weaken protections for Americans with medical debt, issuing new guidance that threatens ongoing state efforts to keep that debt off consumers’ ...

Why does it matter to pharma companies? How Syneos Health Communications can help; Whether you work in healthcare communications, pharmaceutical marketing or biotech ...

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

This year’s survey shows AI is no longer theoretical — it is fully embedded across the medical marketing industry. The Agency 100 is MM+M’s annual ranking of the industry’s top healthcare marketing ...

Synthetic audience testing is here to stay, but its value depends on how it’s done. Resonance Read introduces a more behaviorally precise, evidence-based way forward.

Citing a ProPublica investigation, lawmakers are calling on the FDA to conduct more drug testing and to alert hospitals and other purchasers when foreign manufacturers with safety failures are given a ...

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

Citing a ProPublica investigation, lawmakers are calling on the FDA to conduct more drug testing and to alert hospitals and other purchasers when foreign manufacturers with safety failures are given a ...